[DNLI] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -154.18%
YoY- 3.82%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 1,267 3,559 5,285 9,393 13,604 1,195 -
PBT -107,192 -99,353 -103,299 -84,588 -58,172 -46,373 -35,371 20.27%
Tax 0 2,257 2,114 782 56 -113 0 -
NP -107,192 -99,353 -103,299 -84,588 -58,228 -46,260 -35,371 20.27%
Tax Rate - - - - - - - -
Total Cost 107,192 100,620 106,858 89,873 67,621 59,864 36,566 19.61%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 -7,841.59 -2,902.47 -1,600.53 -619.91 -340.05 -2,959.92 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.63 -0.72 -0.84 -0.69 -0.54 -0.48 -0.38 8.78%
EPS Diluted -0.63 -0.72 -0.84 -0.69 -0.54 -0.48 -0.38 8.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.